• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS ONE. Rapid Detection of the H275Y Oseltamivir Resistance Mutation in Influenza A/H1N1 2009 by Single Base Pair RT-PCR and High-Resolution Melting

Giuseppe

Emeritus
[Source: PLoS ONE, full text: (LINK). Abstract, edited.]

Rapid Detection of the H275Y Oseltamivir Resistance Mutation in Influenza A/H1N1 2009 by Single Base Pair RT-PCR and High-Resolution Melting



Steven Y. C. Tong et al.

by Steven Y. C. Tong, Farshid Dakh, Aeron C. Hurt, Yi-Mo Deng, Kevin Freeman, Peter K. Fagan, Ian G. Barr, Philip M. Giffard


Introduction

We aimed to design a real-time reverse-transcriptase-PCR (rRT-PCR), high-resolution melting (HRM) assay to detect the H275Y mutation that confers oseltamivir resistance in influenza A/H1N1 2009 viruses.


Findings

A novel strategy of amplifying a single base pair, the relevant SNP at position 823 of the neuraminidase gene, was chosen to maintain specificity of the assay. Wildtype and mutant virus were differentiated when using known reference samples of cell-cultured virus. However, when dilutions of these reference samples were assayed, amplification of non-specific primer-dimer was evident and affected the overall melting temperature (T<SUB>m</SUB>) of the amplified products. Due to primer-dimer appearance at >30 cycles we found that if the cycle threshold (C<SUB>T</SUB>) for a dilution was >30, the HRM assay did not consistently discriminate mutant from wildtype. Where the C<SUB>T</SUB> was T and T<SUB>m</SUB> and fitted quadratic curves allowed the discrimination of wildtype, mutant and 30∶70 mutant∶wildtype virus mixtures. We compared the C<SUB>T</SUB> values for a TaqMan H1N1 09 detection assay with those for the HRM assay using 59 clinical samples and demonstrated that samples with a TaqMan detection assay C<SUB>T</SUB>>32.98 would have an H275Y assay C<SUB>T</SUB>>30. Analysis of the TaqMan C<SUB>T</SUB> values for 609 consecutive clinical samples predicted that 207 (34%) of the samples would result in an HRM assay C<SUB>T</SUB>>30 and therefore not be amenable to the HRM assay.


Conclusions
The use of single base pair PCR and HRM can be useful for specifically interrogating SNPs. When applied to H1N1 09, the constraints this placed on primer design resulted in amplification of primer-dimer products. The impact primer-dimer had on HRM curves was adjusted for by plotting T<SUB>m</SUB> against C<SUB>T</SUB>. Although less sensitive than TaqMan assays, the HRM assay can rapidly, and at low cost, screen samples with moderate viral concentrations.

- -------
 
Back
Top Bottom